Papers in Journals
Žiga Bizjak, Žiga Špiclin
Biomedicines, 11(11):2921, 2023
JCR Impact Factor: 3.9 (2023) -- Best Category: 85/354 pharmacology & pharmacy -- Quartile: 1
Abstracts in Conference Proceedings
Žiga Bizjak, Gregor Brecl Jakob, Žiga Špiclin
9th Joint ECTRIMS-ACTRIMS meeting - MSMilan2023, Oct 11-13, Milan, Italy, Multiple Scleroris Journal 29(Suppl 3):752-753, 2023